SCHEMBL6864576

SCHEMBL6864576

CC(C)(C)CC(C)(C)c1cc(/N=N/c2cc(C(F)(F)F)ccc2[N+](=O)[O-])c(O)c(C(C)(C)c2ccc(F)cc2)c1

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.38
HTT P42858 2/20 0.38
GAA P10253 3/20 0.38
ALDH1A1 P00352 2/20 0.38
MAPK1 P28482 2/20 0.38
KDM4E B2RXH2 1/20 0.38
AR P10275 3/20 0.36
LMNA P02545 3/20 0.34
KMT2A Q03164 2/20 0.34
POLQ O75417 1/20 0.34
MEN1 O00255 1/20 0.34
ALOX12 P18054 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
TTR P02766 1/20 0.33
GPR35 Q9HC97 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6864578 0.87 MAPT (0.38) MAPTHTTGAAALDH1A1MAPK1
SCHEMBL6860822 0.87 MAPT (0.44) MAPTGAAALDH1A1MAPK1KDM4E
SCHEMBL6868079 0.87 MAPT (0.44) MAPTGAAALDH1A1MAPK1KDM4E
SCHEMBL5185713 0.82 CES2 (0.39) MAPTKMT2AMEN1GPR35
SCHEMBL5185716 0.82 CES2 (0.39) MAPTKMT2AMEN1GPR35
SCHEMBL29809621 0.82 CES2 (0.39) MAPTKMT2AMEN1GPR35
SCHEMBL6862477 0.80 MAPT (0.43) MAPTHTTGAAALDH1A1MAPK1
SCHEMBL6862475 0.80 MAPT (0.43) MAPTHTTGAAALDH1A1MAPK1
SCHEMBL7524124 0.79 MAPT (0.44) MAPTGAAALDH1A1MAPK1KDM4E
SCHEMBL10385273 0.78 GPR35 (0.41) MAPTHTTGAAALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6800676-B2 ULTRAVIOLET RADIATION ABSORBERS; HEAT AND OXIDATION RESISTANCE CIBA SPECIALTY CHEMICALS CORPORATION 2004-10-05 US disclosed
EP-1305297-A1 BENZOTRIAZOLES CONTAINING ALPHA-CUMYL GROUPS SUBSTITUTED BY HETEROATOMS AND COMPOSITIONS STABILIZED THEREWITH Ciba SC Holding AG (CH) 2003-05-02 EP disclosed
US-20030004235-A1 Benzotriazoles containing phenyl groups substituted by heteroatoms and compositions stabilized therewith CIBA SPECIALTY CHEMICALS CORP. 2003-01-02 US disclosed
US-6451887-B1 Benzotriazoles containing α-cumyl groups substituted by heteroatoms and compositions stabilized therewith CIBA SPECIALTY CHEMICALS CORPORATION 2002-09-17 US disclosed
WO-2002012205-A1 BENZOTRIAZOLES CONTAINING α-CUMYL GROUPS SUBSTITUTED BY HETEROATOMS AND COMPOSITIONS STABILIZED THEREWITH CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2002-02-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030004235-A1 Benzotriazoles containing phenyl groups substituted by heteroatoms and compositions stabilized therewith SUV39H1, SUV39H2, TPST2 MAPT 119/4885HTT 252/4885GAA 2317/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.